• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, March 21

Biocon said it had begun work on the new research facility of its subsidiary Syngene and its US research partner Bristol-Myers Squibb Co. A ground breaking ceremony was held on Wednesday. Dr Francis Cuss, Senior Vice-President, Pharmaceutical Research Institute, BMS, laid the foundation stone. The dedicated facility at the Biocon Park, a captive SEZ, will house 400 scientists in the next three years. The centre is aimed at advancing BMS's discovery and early drug development in India.

More Stories on : Research & Development | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
AstraZeneca global downsizing will not touch India, says CEO

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line